ORBA

ORBA is a specialized contract research organization (CRO) that leverages zebrafish models to accelerate drug discovery and development for pharmaceutical and biotechnology companies. The company provides high-throughput screening services, toxicity assessments, and efficacy testing across various therapeutic areas, including rare diseases, oncology, and cardiovascular health. By utilizing the unique biological advantages of zebrafish, such as their genetic similarity to humans and transparent embryos, ORBA offers a cost-effective and rapid alternative to traditional mammalian animal testing. Their services are designed to bridge the gap between in vitro assays and clinical trials, helping clients identify promising lead compounds earlier in the development cycle.